Proton radiotherapy

Treatment with protons (a kind of charged particles) is a promising development in the field of modern radiation oncology. The physical properties of protons allow a better dose distribution as compared to current photon (X-ray) radiotherapy. This has the potential to minimize the dose to normal tissues and significantly reduce acute and late side effects. The result may be a more effective and less toxic radiation technique.

Committee

Prof. M. de Visser MD PhD, Professor of Neurology/Neuromuscular diseases, Academic Medical Centre Amsterdam, vice-president of the Health Council of The Netherlands, The Hague, chair
Prof. J.W.H. Leer MD PhD, Professor of Radiotherapy, University Medical Centre St. Radboud, Nijmegen, vice-chair
J.A.M. van Doorn, Policy advisor Curative Care, Ministry of Health, The Hague, observer
G.L. Engel PhD, Consultancy Bureau ‘De Hemel’, Soest, observer
A.G. Koppejan-Rensenbrink, Board of Governors, Integraal Kankercentrum Midden Nederland, Utrecht
Prof. J.A. Langendijk MD PhD, Professor of Radiotherapy, University Medical Centre Groningen
Prof. F.E. van Leeuwen, PhD, Professor of Epidemiology, Netherlands Cancer Institute, Antoni van Leeuwenhoek Hospital, Amsterdam
Prof. P.C. Levendag MD PhD, Professor of Radiotherapy, Erasmus Medical Centre, Daniël den Hoed Clinic, Rotterdam
M.J.M. van der Ouderaa, Manager Department of Radiotherapy, Academic Medical Centre, Amsterdam
A. Slot MD, Radiotherapist, Director of the Radiotherapy Insitute Friesland, Leeuwarden
Prof. B.J. Slotman MD PhD, Professor of Radiotherapy, Free University Medical Centre, Amsterdam
P.H. Vos PhD, Physicist, Dr. Bernard Verbeeten Institute, Tilburg
J. Welleweerd, Physicist, University Medical Centre Utrecht
M.A. Bos, Health Council of The Netherlands, The Hague, secretary